Annual Net Income
$5.72 B
-$1.21 B-17.45%
31 December 2023
Summary:
Abbott Laboratories annual net profit is currently $5.72 billion, with the most recent change of -$1.21 billion (-17.45%) on 31 December 2023. During the last 3 years, it has risen by +$1.23 billion (+27.32%). ABT annual net income is now -19.06% below its all-time high of $7.07 billion, reached on 31 December 2021.ABT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.65 B
+$344.00 M+26.42%
30 September 2024
Summary:
Abbott Laboratories quarterly net profit is currently $1.65 billion, with the most recent change of +$344.00 million (+26.42%) on 30 September 2024. Over the past year, it has increased by +$210.00 million (+14.62%). ABT quarterly net income is now -32.73% below its all-time high of $2.45 billion, reached on 31 March 2022.ABT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$5.77 B
+$210.00 M+3.78%
30 September 2024
Summary:
Abbott Laboratories TTM net profit is currently $5.77 billion, with the most recent change of +$210.00 million (+3.78%) on 30 September 2024. Over the past year, it has increased by +$605.00 million (+11.72%). ABT TTM net income is now -32.58% below its all-time high of $8.55 billion, reached on 30 June 2022.ABT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.4% | +14.6% | +11.7% |
| 3 y3 years | +27.3% | -21.6% | -20.4% |
| 5 y5 years | +141.7% | +71.5% | +75.2% |
ABT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.1% | +27.3% | -32.7% | +59.3% | -32.6% | +11.7% |
| 5 y | 5 years | -19.1% | +141.7% | -32.7% | +206.5% | -32.6% | +85.4% |
| alltime | all time | -19.1% | +1321.5% | -32.7% | +298.8% | -32.6% | +6475.8% |
Abbott Laboratories Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.65 B(+26.4%) | $5.77 B(+3.8%) |
| June 2024 | - | $1.30 B(+6.3%) | $5.56 B(-1.3%) |
| Mar 2024 | - | $1.23 B(-23.1%) | $5.63 B(-1.6%) |
| Dec 2023 | $5.72 B(-17.5%) | $1.59 B(+11.0%) | $5.72 B(+10.9%) |
| Sept 2023 | - | $1.44 B(+4.4%) | $5.16 B(+0.0%) |
| June 2023 | - | $1.38 B(+4.3%) | $5.16 B(-11.1%) |
| Mar 2023 | - | $1.32 B(+27.6%) | $5.80 B(-16.3%) |
| Dec 2022 | $6.93 B(-2.0%) | $1.03 B(-28.0%) | $6.93 B(-12.1%) |
| Sept 2022 | - | $1.44 B(-28.9%) | $7.89 B(-7.8%) |
| June 2022 | - | $2.02 B(-17.5%) | $8.55 B(+10.7%) |
| Mar 2022 | - | $2.45 B(+23.0%) | $7.72 B(+9.2%) |
| Dec 2021 | $7.07 B(+57.3%) | $1.99 B(-5.3%) | $7.07 B(-2.4%) |
| Sept 2021 | - | $2.10 B(+76.6%) | $7.24 B(+13.6%) |
| June 2021 | - | $1.19 B(-33.7%) | $6.38 B(+11.4%) |
| Mar 2021 | - | $1.79 B(-17.1%) | $5.72 B(+27.3%) |
| Dec 2020 | $4.50 B(+21.9%) | $2.16 B(+75.5%) | $4.50 B(+32.9%) |
| Sept 2020 | - | $1.23 B(+129.4%) | $3.38 B(+8.7%) |
| June 2020 | - | $537.00 M(-4.8%) | $3.11 B(-13.1%) |
| Mar 2020 | - | $564.00 M(-46.2%) | $3.58 B(-2.9%) |
| Dec 2019 | $3.69 B(+55.7%) | $1.05 B(+9.3%) | $3.69 B(+12.0%) |
| Sept 2019 | - | $960.00 M(-4.6%) | $3.29 B(+13.7%) |
| June 2019 | - | $1.01 B(+49.7%) | $2.90 B(+10.4%) |
| Mar 2019 | - | $672.00 M(+2.8%) | $2.62 B(+10.7%) |
| Dec 2018 | $2.37 B(+396.4%) | $654.00 M(+16.2%) | $2.37 B(+167.3%) |
| Sept 2018 | - | $563.00 M(-23.2%) | $886.00 M(-4.3%) |
| June 2018 | - | $733.00 M(+75.4%) | $926.00 M(+94.5%) |
| Mar 2018 | - | $418.00 M(-150.5%) | $476.00 M(-0.2%) |
| Dec 2017 | $477.00 M(-65.9%) | -$828.00 M(-237.3%) | $477.00 M(-77.3%) |
| Sept 2017 | - | $603.00 M(+113.1%) | $2.10 B(+79.6%) |
| June 2017 | - | $283.00 M(-32.5%) | $1.17 B(-22.1%) |
| Mar 2017 | - | $419.00 M(-47.5%) | $1.50 B(+7.4%) |
| Dec 2016 | $1.40 B(-68.3%) | $798.00 M(-342.6%) | $1.40 B(+2.3%) |
| Sept 2016 | - | -$329.00 M(-153.5%) | $1.37 B(-39.9%) |
| June 2016 | - | $615.00 M(+94.6%) | $2.28 B(-6.9%) |
| Mar 2016 | - | $316.00 M(-58.8%) | $2.45 B(-44.7%) |
| Dec 2015 | $4.42 B(+93.7%) | $767.00 M(+32.2%) | $4.42 B(-3.0%) |
| Sept 2015 | - | $580.00 M(-26.0%) | $4.56 B(+0.9%) |
| June 2015 | - | $784.00 M(-65.8%) | $4.52 B(+7.6%) |
| Mar 2015 | - | $2.29 B(+153.5%) | $4.20 B(+84.0%) |
| Dec 2014 | $2.28 B(-11.3%) | $904.00 M(+68.0%) | $2.28 B(+16.0%) |
| Sept 2014 | - | $538.00 M(+15.5%) | $1.97 B(-17.9%) |
| June 2014 | - | $466.00 M(+24.3%) | $2.40 B(-0.4%) |
| Mar 2014 | - | $375.00 M(-36.3%) | $2.41 B(-6.6%) |
| Dec 2013 | $2.58 B(-56.8%) | $589.00 M(-39.0%) | $2.58 B(-15.3%) |
| Sept 2013 | - | $966.00 M(+102.9%) | $3.04 B(-24.3%) |
| June 2013 | - | $476.00 M(-12.5%) | $4.02 B(-23.7%) |
| Mar 2013 | - | $544.00 M(-48.4%) | $5.26 B(-11.7%) |
| Dec 2012 | $5.96 B(+26.1%) | $1.05 B(-45.8%) | $5.96 B(-8.7%) |
| Sept 2012 | - | $1.94 B(+12.7%) | $6.53 B(+33.5%) |
| June 2012 | - | $1.72 B(+38.8%) | $4.89 B(-4.3%) |
| Mar 2012 | - | $1.24 B(-23.2%) | $5.11 B(+8.0%) |
| Dec 2011 | $4.73 B(+2.2%) | $1.62 B(+433.7%) | $4.73 B(+3.9%) |
| Sept 2011 | - | $303.18 M(-84.4%) | $4.55 B(-11.4%) |
| June 2011 | - | $1.94 B(+124.9%) | $5.14 B(+14.5%) |
| Mar 2011 | - | $863.82 M(-40.0%) | $4.49 B(-3.0%) |
| Dec 2010 | $4.63 B(-19.5%) | $1.44 B(+61.8%) | $4.63 B(-2.1%) |
| Sept 2010 | - | $890.66 M(-31.0%) | $4.72 B(-11.1%) |
| June 2010 | - | $1.29 B(+28.8%) | $5.31 B(+0.1%) |
| Mar 2010 | - | $1.00 B(-34.8%) | $5.31 B(-7.6%) |
| Dec 2009 | $5.75 B(+17.7%) | $1.54 B(+3.9%) | $5.75 B(+0.0%) |
| Sept 2009 | - | $1.48 B(+14.9%) | $5.74 B(+7.4%) |
| June 2009 | - | $1.29 B(-10.5%) | $5.35 B(-0.6%) |
| Mar 2009 | - | $1.44 B(-6.4%) | $5.38 B(+10.3%) |
| Dec 2008 | $4.88 B(+35.3%) | $1.54 B(+41.6%) | $4.88 B(+7.3%) |
| Sept 2008 | - | $1.08 B(-18.0%) | $4.55 B(+8.8%) |
| June 2008 | - | $1.32 B(+41.0%) | $4.18 B(+8.7%) |
| Mar 2008 | - | $937.87 M(-22.0%) | $3.85 B(+6.7%) |
| Dec 2007 | $3.61 B(+110.1%) | $1.20 B(+67.8%) | $3.61 B(+87.1%) |
| Sept 2007 | - | $717.00 M(-27.5%) | $1.93 B(+0.1%) |
| June 2007 | - | $988.74 M(+41.7%) | $1.93 B(+24.3%) |
| Mar 2007 | - | $697.54 M(-246.5%) | $1.55 B(-9.7%) |
| Dec 2006 | $1.72 B(-49.1%) | -$476.21 M(-166.5%) | $1.72 B(-45.8%) |
| Sept 2006 | - | $715.84 M(+16.9%) | $3.17 B(+1.1%) |
| June 2006 | - | $612.24 M(-29.2%) | $3.13 B(-7.8%) |
| Mar 2006 | - | $864.88 M(-11.4%) | $3.40 B(+0.8%) |
| Dec 2005 | $3.37 B(+4.2%) | $976.42 M(+43.4%) | $3.37 B(+0.1%) |
| Sept 2005 | - | $680.71 M(-22.4%) | $3.37 B(-3.5%) |
| June 2005 | - | $877.05 M(+4.7%) | $3.49 B(+7.5%) |
| Mar 2005 | - | $837.89 M(-14.0%) | $3.25 B(+0.5%) |
| Dec 2004 | $3.24 B | $974.61 M(+21.2%) | $3.24 B(+0.9%) |
| Sept 2004 | - | $804.08 M(+26.8%) | $3.21 B(+1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2004 | - | $634.26 M(-22.9%) | $3.16 B(+14.0%) |
| Mar 2004 | - | $822.91 M(-12.9%) | $2.78 B(+0.8%) |
| Dec 2003 | $2.75 B(-1.4%) | $944.39 M(+24.1%) | $2.75 B(+13.0%) |
| Sept 2003 | - | $761.22 M(+208.6%) | $2.44 B(+1.7%) |
| June 2003 | - | $246.64 M(-69.2%) | $2.39 B(-12.6%) |
| Mar 2003 | - | $800.98 M(+27.7%) | $2.74 B(-1.9%) |
| Dec 2002 | $2.79 B(+80.2%) | $627.11 M(-12.9%) | $2.79 B(+0.5%) |
| Sept 2002 | - | $720.05 M(+21.6%) | $2.78 B(+3.3%) |
| June 2002 | - | $592.26 M(-30.7%) | $2.69 B(+2.4%) |
| Mar 2002 | - | $854.28 M(+39.2%) | $2.63 B(+69.5%) |
| Dec 2001 | $1.55 B(-44.4%) | $613.55 M(-2.8%) | $1.55 B(-8.3%) |
| Sept 2001 | - | $631.40 M(+19.3%) | $1.69 B(-1.3%) |
| June 2001 | - | $529.05 M(-336.6%) | $1.71 B(-8.4%) |
| Mar 2001 | - | -$223.61 M(-129.7%) | $1.87 B(-32.9%) |
| Dec 2000 | $2.79 B(+13.9%) | $753.40 M(+15.1%) | $2.79 B(+3.3%) |
| Sept 2000 | - | $654.42 M(-4.5%) | $2.70 B(+7.4%) |
| June 2000 | - | $685.20 M(-1.1%) | $2.51 B(+1.6%) |
| Mar 2000 | - | $692.96 M(+4.4%) | $2.47 B(+1.0%) |
| Dec 1999 | $2.45 B(+4.8%) | $664.04 M(+41.9%) | $2.45 B(+1.5%) |
| Sept 1999 | - | $468.08 M(-27.4%) | $2.41 B(-2.6%) |
| June 1999 | - | $645.00 M(-3.5%) | $2.47 B(+2.5%) |
| Mar 1999 | - | $668.70 M(+6.6%) | $2.41 B(+3.4%) |
| Dec 1998 | $2.33 B(+12.3%) | $627.50 M(+18.0%) | $2.33 B(+3.4%) |
| Sept 1998 | - | $531.70 M(-9.2%) | $2.26 B(+2.7%) |
| June 1998 | - | $585.57 M(-0.7%) | $2.20 B(+3.0%) |
| Mar 1998 | - | $589.60 M(+6.9%) | $2.13 B(+2.6%) |
| Dec 1997 | $2.08 B(+10.5%) | $551.30 M(+16.9%) | $2.08 B(+2.0%) |
| Sept 1997 | - | $471.40 M(-9.6%) | $2.04 B(+2.5%) |
| June 1997 | - | $521.53 M(-2.5%) | $1.99 B(+2.6%) |
| Mar 1997 | - | $534.83 M(+4.7%) | $1.94 B(+2.9%) |
| Dec 1996 | $1.88 B(+11.4%) | $510.58 M(+21.3%) | $1.88 B(+2.5%) |
| Sept 1996 | - | $420.89 M(-10.5%) | $1.84 B(+2.2%) |
| June 1996 | - | $470.40 M(-2.0%) | $1.80 B(+2.6%) |
| Mar 1996 | - | $480.10 M(+3.2%) | $1.75 B(+3.7%) |
| Dec 1995 | $1.69 B(+11.3%) | $465.37 M(+21.8%) | $1.69 B(+2.6%) |
| Sept 1995 | - | $382.05 M(-9.9%) | $1.65 B(+1.9%) |
| June 1995 | - | $424.03 M(+1.6%) | $1.62 B(+3.0%) |
| Mar 1995 | - | $417.25 M(-1.3%) | $1.57 B(+3.4%) |
| Dec 1994 | $1.52 B(+8.4%) | $422.55 M(+20.3%) | $1.52 B(+2.1%) |
| Sept 1994 | - | $351.34 M(-6.7%) | $1.49 B(+2.4%) |
| June 1994 | - | $376.56 M(+2.8%) | $1.45 B(+2.1%) |
| Mar 1994 | - | $366.23 M(-6.4%) | $1.42 B(+1.5%) |
| Dec 1993 | $1.40 B(+12.9%) | $391.33 M(+23.8%) | $1.40 B(+3.1%) |
| Sept 1993 | - | $316.20 M(-8.6%) | $1.36 B(+2.8%) |
| June 1993 | - | $346.10 M(+0.2%) | $1.32 B(+2.2%) |
| Mar 1993 | - | $345.50 M(-1.0%) | $1.29 B(+4.1%) |
| Dec 1992 | $1.24 B(+13.8%) | $349.00 M(+25.2%) | $1.24 B(+2.8%) |
| Sept 1992 | - | $278.80 M(-12.1%) | $1.20 B(+2.3%) |
| June 1992 | - | $317.10 M(+7.8%) | $1.18 B(+4.3%) |
| Mar 1992 | - | $294.20 M(-6.5%) | $1.13 B(+3.7%) |
| Dec 1991 | $1.09 B(+12.7%) | $314.80 M(+25.1%) | $1.09 B(+3.3%) |
| Sept 1991 | - | $251.60 M(-6.2%) | $1.05 B(+3.0%) |
| June 1991 | - | $268.30 M(+5.6%) | $1.02 B(+2.8%) |
| Mar 1991 | - | $254.10 M(-9.2%) | $994.90 M(+3.0%) |
| Dec 1990 | $965.80 M(+12.3%) | $279.80 M(+26.7%) | $965.80 M(+2.9%) |
| Sept 1990 | - | $220.80 M(-8.1%) | $939.00 M(+2.7%) |
| June 1990 | - | $240.20 M(+6.8%) | $914.50 M(+3.1%) |
| Mar 1990 | - | $225.00 M(-11.1%) | $886.90 M(+3.1%) |
| Dec 1989 | $859.80 M(+14.3%) | $253.00 M(+28.9%) | $859.90 M(+3.7%) |
| Sept 1989 | - | $196.30 M(-7.7%) | $829.20 M(+3.0%) |
| June 1989 | - | $212.60 M(+7.4%) | $805.20 M(+3.5%) |
| Mar 1989 | - | $198.00 M(-10.9%) | $777.90 M(+3.4%) |
| Dec 1988 | $752.00 M(+18.9%) | $222.30 M(+29.0%) | $752.00 M(+4.5%) |
| Sept 1988 | - | $172.30 M(-7.0%) | $719.80 M(+3.8%) |
| June 1988 | - | $185.30 M(+7.7%) | $693.30 M(+4.6%) |
| Mar 1988 | - | $172.10 M(-9.5%) | $663.10 M(+4.8%) |
| Dec 1987 | $632.60 M(+17.0%) | $190.10 M(+30.4%) | $632.60 M(+4.9%) |
| Sept 1987 | - | $145.80 M(-6.0%) | $603.10 M(+4.0%) |
| June 1987 | - | $155.10 M(+9.5%) | $580.10 M(+3.8%) |
| Mar 1987 | - | $141.60 M(-11.8%) | $558.60 M(+3.3%) |
| Dec 1986 | $540.50 M(+16.2%) | $160.60 M(+30.8%) | $540.50 M(+3.7%) |
| Sept 1986 | - | $122.80 M(-8.1%) | $521.30 M(+3.2%) |
| June 1986 | - | $133.60 M(+8.2%) | $505.20 M(+3.8%) |
| Mar 1986 | - | $123.50 M(-12.7%) | $486.60 M(+4.6%) |
| Dec 1985 | $465.30 M(+15.6%) | $141.40 M(+32.5%) | $465.30 M(+4.1%) |
| Sept 1985 | - | $106.70 M(-7.2%) | $447.00 M(+3.5%) |
| June 1985 | - | $115.00 M(+12.5%) | $431.70 M(+3.5%) |
| Mar 1985 | - | $102.20 M(-17.0%) | $417.10 M(+3.6%) |
| Dec 1984 | $402.60 M | $123.10 M(+34.7%) | $402.60 M(+44.0%) |
| Sept 1984 | - | $91.40 M(-9.0%) | $279.50 M(+48.6%) |
| June 1984 | - | $100.40 M(+14.5%) | $188.10 M(+114.5%) |
| Mar 1984 | - | $87.70 M | $87.70 M |
FAQ
- What is Abbott Laboratories annual net profit?
- What is the all time high annual net income for Abbott Laboratories?
- What is Abbott Laboratories annual net income year-on-year change?
- What is Abbott Laboratories quarterly net profit?
- What is the all time high quarterly net income for Abbott Laboratories?
- What is Abbott Laboratories quarterly net income year-on-year change?
- What is Abbott Laboratories TTM net profit?
- What is the all time high TTM net income for Abbott Laboratories?
- What is Abbott Laboratories TTM net income year-on-year change?
What is Abbott Laboratories annual net profit?
The current annual net income of ABT is $5.72 B
What is the all time high annual net income for Abbott Laboratories?
Abbott Laboratories all-time high annual net profit is $7.07 B
What is Abbott Laboratories annual net income year-on-year change?
Over the past year, ABT annual net profit has changed by -$1.21 B (-17.45%)
What is Abbott Laboratories quarterly net profit?
The current quarterly net income of ABT is $1.65 B
What is the all time high quarterly net income for Abbott Laboratories?
Abbott Laboratories all-time high quarterly net profit is $2.45 B
What is Abbott Laboratories quarterly net income year-on-year change?
Over the past year, ABT quarterly net profit has changed by +$210.00 M (+14.62%)
What is Abbott Laboratories TTM net profit?
The current TTM net income of ABT is $5.77 B
What is the all time high TTM net income for Abbott Laboratories?
Abbott Laboratories all-time high TTM net profit is $8.55 B
What is Abbott Laboratories TTM net income year-on-year change?
Over the past year, ABT TTM net profit has changed by +$605.00 M (+11.72%)